Acoustic neuroma
MONDO:0001569A type of benign brain tumor that begins in the Schwann cells, which produce the myelin that protects the acoustic nerve - the nerve of hearing.
Also known as: acoustic tumor, acoustic tumour, acoustic neurilemmoma, acoustic neurilemoma, acoustic neurinoma, acoustic neuroma, acoustic schwannoma, neurilemoma, acoustic
1485 clinical trials for this condition and its sub-types, 35 tagged with Acoustic neuroma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Precision radiation may tame nerve tumors without surgery
Disease control CompletedResearchers are reviewing records from 200 adults who received CyberKnife stereotactic radiosurgery for vestibular schwannomas, benign tumors on the nerve that controls hearing and balance. The study compares MRI scans before and after treatment to see if the tumors shrink or sto…
Sponsor: Hartmann Oncology Radiotherapy Group, France • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can splitting radiation save more hearing in acoustic neuroma patients?
Disease control CompletedThis trial tests two ways of delivering Cyberknife radiation to people with acoustic neuromas, benign tumors on the hearing nerve. One group receives a single radiation session, while the other receives three sessions. The goal is to see which approach better preserves useful hea…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a cancer drug shrink NF2 tumors?
Disease control CompletedThis phase 2 trial tested the drug crizotinib in 12 people with neurofibromatosis type 2 (NF2) who had growing tumors in the ear area called vestibular schwannomas. Participants took crizotinib pills daily for up to 12 months. The main goal was to see if the drug could shrink the…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Glowing dye could help surgeons spot hidden brain tumor cells
Diagnosis CompletedThis study tests whether a fluorescent dye called tozuleristide, given before surgery, can make brain tumor tissue glow under a special imaging system. Surgeons can then see and remove more of the tumor while sparing healthy brain. The trial enrolls adults with certain types of b…
Phase 2 • Sponsor: John Yu • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
New Gadolinium-Free MRI dye shows promise for brain scans
Diagnosis CompletedThis study tested a new MRI contrast agent called RVP-001, made with manganese instead of gadolinium, in 18 adults with known brain lesions (like tumors or multiple sclerosis). The goal was to see if it is safe and can detect lesions as well as current gadolinium-based dyes. Each…
Phase 2 • Sponsor: Reveal Pharmaceuticals Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
New MRI scan could help surgeons avoid facial nerve damage during brain tumor removal
Diagnosis CompletedThis study tested a special MRI technique called diffusion tensor tractography (DTT) to map the facial nerve before surgery for vestibular schwannoma, a benign brain tumor. The facial nerve is at risk during surgery, and injury can cause permanent facial weakness. The study invol…
Sponsor: King's College Hospital NHS Trust • Aim: Diagnosis
Last updated Jun 26, 2026 15:32 UTC
-
New nursing approach may ease emotional toll of facial paralysis after brain surgery
Symptom relief CompletedThis study tested a 12-week nursing program based on the Roy Adaptation Model in 160 adults who developed facial paralysis after surgery for a large acoustic neuroma. The program included education, counseling, and facial exercises, and aimed to reduce anxiety and depression whil…
Sponsor: West China Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Leftover tumor tissue used to grow Mini-Tumors in lab
Knowledge-focused CompletedThis study took leftover tumor tissue from 100 patients undergoing surgery for vestibular schwannoma (a non-cancerous brain tumor) and used it to grow stem cell organoids—tiny 3D versions of the tumor—in the lab. The goal was to create a living biobank to study why these tumors r…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC